Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market
2025-10-13 21:40
iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data
2025-10-13 21:00
NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain
2025-10-13 21:00
Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG
2025-10-13 21:00
Thousand Oaks Biologics Shanghai ADC Site receives EU QP Declaration
2025-10-13 20:00
ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease
2025-10-13 18:00
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine
2025-10-13 12:38
Smartee Launches World's First Sleep Aligner Combining Anti-Snoring Therapy with Teeth Alignment
2025-10-13 09:38
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development
2025-10-13 08:10
C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001
2025-10-11 20:45
Renalys Announces Completion of Primary Endpoint Data Collection for Phase III Clinical Trial of Sparsentan for Iga Nephropathy in Japan
2025-10-10 14:00
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year
2025-10-10 08:30
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
2025-10-10 06:56
POMDOCTOR LIMITED Announces Closing of Initial Public Offering
2025-10-10 04:05
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™
2025-10-09 19:00
Advantech AOM-5721 Combines SMARC Design and Qualcomm Dragonwing™ QCS6490 for Next-Gen Edge AI
2025-10-09 17:05
EDAN Expands U.S. Operations with New Manufacturing Hub
2025-10-09 06:53
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025
2025-10-08 22:20
Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System
2025-10-08 21:00
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering
2025-10-08 20:00
1
9
10
11
12
13
490